Probiomics Ltd Report issue

For profit Phase 2
Founded: Gordon NSW Australia (1997)
Status: Defunct (2012)

Organization Overview

First Clinical Trial
2006
NCT00294788
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

fluvax (1 trial)

lactobacillus fermentum (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2